BlackRock, Inc. 13D and 13G filings for G1 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | G1 Therapeutics, Inc. GTHX |
BlackRock Inc. BLK |
1,369,281 3.200% |
-1,940,931 (-58.63%) |
Filing |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
BlackRock Inc. BLK |
3,310,212 7.800% |
416,619 (+14.40%) |
Filing |
| 2021-01-29 09:57 am Purchase |
2020-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
BlackRock Inc. BLK |
2,893,593 7.600% |
313,234 (+12.14%) |
Filing |